The schall law firm has begun an investigation into claims against regeneron pharmaceuticals, inc. (nasdaq:regn) and encourages investors who have suffered losses to make contact

Los angeles, ca / accesswire / june 11, 2024 / the schall law firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of regeneron pharmaceuticals, inc. ("regeneron" or "the company") (nasdaq:regn) for violations of the securities laws. the investigation focuses on whether the company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
REGN Ratings Summary
REGN Quant Ranking